Who depends on I Mab Biopharma
I Mab Biopharma appears in 1 disclosed customer relationships between 2021 and 2024.
Get an email when I Mab Biopharma's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Suppliers that depend on I Mab Biopharma
Listed companies whose annual report names I Mab Biopharma as a customer worth 10% or more of their revenue. If I Mab Biopharma cuts orders or switches supplier, these are the companies that feel it.
Formerly disclosed
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| MacrogenicsMGNX | 16% | last FY 2021 | 1 year | FY 2021 · filed 7 Mar 2024 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API